GT BIOPHARMA (GTBP)
$2.32
0.08 (3.45%)
GTBP Stock Earnings: GT Biopharma Reported Results for Q2 2024
GT Biopharma just reported results for the second quarter of 2024.

Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:

Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:

Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:

Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
$2.30
Market Cap
5.14M
PE Ratio
-0.33
EPS
-6.9491
Volume (Avg. Vol.)
15,610
Day's Range
$2.35 - $2.43
52-Week Range
$1.72 - $10.66
Dividend & Yield
N/A (N/A)